Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Saturday, January 25, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
admin
-
January 24, 2025
Latest Pharma-News
Bayer and Pula Foundation partner up to insure 10 million smallholder farmers in Sub-Saharan Africa and South Asia
admin
-
January 24, 2025
Latest Pharma-News
First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease
admin
-
January 18, 2025
Latest Pharma-News
Johnson & Johnson initiated submission of NDA application with U.S. FDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer
admin
-
January 18, 2025
Latest Pharma-News
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
admin
-
March 8, 2024
Latest Pharma-News
Y-mAbs Announces Positive Pre-Biologics License Application Meeting with FDA for Omburtamab
admin
-
February 27, 2020
0
Latest Pharma-News
NIH clinical trial of remdesivir to treat coronavirus disease 2019 (COVID-19) begins
admin
-
February 27, 2020
0
Latest Pharma-News
Novartis announces FDA and EMA filing acceptance of ofatumumab (OMB157), a novel B-cell therapy for patients with relapsing forms of multiple sclerosis (RMS)
admin
-
February 27, 2020
0
Latest Pharma-News
Novartis receives EC Approval for Beovu®(brolucizumab), a next-generation anti-VEGF treatment for wet AMD, a leading cause of blindness worldwide
admin
-
February 20, 2020
0
Latest Pharma-News
US FDA Grants Orphan Drug Designation for Retrotope’s RT001 in the Treatment of Progressive SupraNuclear Palsy (PSP)
admin
-
February 19, 2020
0
Latest Pharma-News
MediciNova Receives Notice of Allowance from the Japan Patent Office for New Patent Covering MN-001 and MN-002 for the Treatment of Advanced NASH...
admin
-
February 19, 2020
0
Latest Pharma-News
Arctoris announces a formal partnership with Molecule to tackle the innovation crisis in the drug discovery and development
admin
-
February 18, 2020
0
Latest Pharma-News
Lupin received approval from U.S. FDA and launches Moxifloxacin Ophthalmic Solution USP 0.5%
admin
-
February 18, 2020
0
Latest Pharma-News
FDA grant approval for GSK’s Voltaren Arthritis Pain for over-the-counter use in the United States
admin
-
February 18, 2020
0
Latest Pharma-News
Health ministry issues notification to regulate all the medical devices under D&C Act from April 1, 2020
admin
-
February 17, 2020
0
Latest Pharma-News
New Phase IIIb Interim Data from the STARDUST Study Shows about Two-Thirds of Patients with Moderately to Severely Active Crohn’s Disease Achieved Clinical Remission...
admin
-
February 17, 2020
0
Latest Pharma-News
Deciphera Pharmaceuticals Announces U.S. FDA Acceptance of NDA and Priority Review for Ripretinib in the Patients with Advanced Gastrointestinal Stromal Tumors
admin
-
February 17, 2020
0
1
...
127
128
129
...
145
Page 128 of 145
- Advertisment -
Most Read
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
January 24, 2025
Bayer and Pula Foundation partner up to insure 10 million smallholder farmers in Sub-Saharan Africa and South Asia
January 24, 2025
First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease
January 18, 2025
Johnson & Johnson initiated submission of NDA application with U.S. FDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer
January 18, 2025